Recent studies have identified SLC13A3 as an importer of itaconate, with SLC13A3-mediated uptake contributing to tumor immune evasion, resistance to ferroptosis, and hepatic antibacterial innate immunity 48-50. Here, SLC13A3 is linked to neoplasm.